R4 Draft for Comment

This page is part of the FHIR Specification (v3.2.0: R4 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions

Biomedical Research and Regulation Work GroupMaturity Level: 0 Draft Compartments: Not linked to any defined compartments

Detailed Descriptions for the elements in the MedicinalProductPharmaceutical resource.

MedicinalProductPharmaceutical
Definition

A pharmaceutical product described in terms of its composition and dose form.

Control1..1
Summarytrue
MedicinalProductPharmaceutical.identifier
Definition

An identifier for the pharmaceutical medicinal product.

NoteThis is a business identifer, not a resource identifier (see discussion)
Control0..*
TypeIdentifier
Summarytrue
MedicinalProductPharmaceutical.administrableDoseForm
Definition

The administrable dose form, after necessary reconstitution.

Control1..1
TypeCodeableConcept
Summarytrue
MedicinalProductPharmaceutical.unitOfPresentation
Definition

Todo.

Control0..1
TypeCodeableConcept
Summarytrue
MedicinalProductPharmaceutical.routeOfAdministration
Definition

The path by which the pharmaceutical product is taken into or makes contact with the body.

Control1..*
TypeCodeableConcept
Summarytrue
MedicinalProductPharmaceutical.ingredient
Definition

Ingredient.

Control0..*
TypeReference(MedicinalProductIngredient)
Summarytrue
MedicinalProductPharmaceutical.device
Definition

Accompanying device.

Control0..*
Typestring
Summarytrue
MedicinalProductPharmaceutical.characteristics
Definition

Characteristics e.g. a products onset of action.

Control0..*
Summarytrue
MedicinalProductPharmaceutical.characteristics.code
Definition

A coded characteristic.

Control1..1
TypeCodeableConcept
Summarytrue
MedicinalProductPharmaceutical.characteristics.status
Definition

The status of characteristic e.g. assigned or pending.

Control0..1
TypeCodeableConcept
Summarytrue